Clearmind Medicine
CMND
1 hedge funds and large institutions have $148K invested in Clearmind Medicine in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$191K |
Top Sellers
CMND Hedge Fund Activity: Q4 2022 in Review
1 of the 6,076 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q4 2022, worth a combined $148K.
Buyers outnumbered sellers: 1 fund opened new CMND positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Walleye Capital, opening a new position worth an estimated $191K.
- 1 institutional investor held Clearmind Medicine (CMND) as of Q4 2022, up from 0 in Q3 2022.
- Funds reported $148K of Clearmind Medicine stock for Q4 2022.
- 1 fund opened new Clearmind Medicine positions in Q4 2022 and 0 closed out, a net change of +1 holder.
- The largest Clearmind Medicine buyer in Q4 2022 was Walleye Capital, an estimated $191K added.
Based on aggregated 13F filings for Q4 2022.